Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-05-001434
Filing Date
2005-03-15
Accepted
2005-03-15 15:52:32
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 OXIGENE INC FORM 10-K b54064oie10vk.htm 10-K 652092
2 EX-10.41 DESCRIPTION OF DIRECTOR COMPENSATION b54064oiexv10w41.htm EX-10.41 1839
3 EX-10.42 NAMED EXECUTIVE OFFICERS COMPENSATION ARRANGEMENTS b54064oiexv10w42.htm EX-10.42 4370
4 EX-23 CONSENT OF ERNST & YOUNG LLP b54064oiexv23.htm EX-23 2309
5 EX-31.1 SECTION 302 CERTIFICATION OF CEO b54064oiexv31w1.htm EX-31.1 7575
6 EX-31.2 SECTION 302 CERTIFICATION OF CFO b54064oiexv31w2.htm EX-31.2 7630
7 EX-32 SECTION 906 CERTIFICATION b54064oiexv32.htm EX-32 3658
  Complete submission text file 0000950135-05-001434.txt   681781
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 05681696
SIC: 2836 Biological Products, (No Diagnostic Substances)